Skip to Content

Clorox Co

CLX: XNYS (USA)
View Stock Summary
Morningstar Rating for Stocks Fair Value Economic Moat Capital Allocation
$979.00FdqKqnxrdkvf

Clorox Toggling Multiple Levers To Rebuild Margins While Resolutely Focusing on Brand Investments

Business Strategy and Outlook

While volume growth has been hard to come by since the pandemic prompted consumers to scour the shelves for Clorox’s fare, we don’t think consumers are turning their backs on Clorox’s cleaning and disinfecting products, as overall sales remain well above where they were before the pandemic, to the tune of 20%-30% of late. This prowess is further evidenced by its disinfecting wipes offering, which has been gaining market share.

Free Trial of Morningstar Investor

Get our analysts’ objective, in-depth, and continuous investment coverage of CLX so you can make buy / sell decisions free of market noise.

Start Free Trial

Sponsor Center